It has been reported that miR-409-3p targets PHF10, radixin and c-Met [8, 9, 11, 19] Here, we found that NLK could be a potential target of miR-409-3p since NLK would be the potential target in the CRC scenario. Here, RDX is linked to colorectal carcinoma.